Attach importance to precision and personalized treatment procedures of multiple sclerosis
10.3760/cma.j.cn113694-20221212-00936
- VernacularTitle:重视多发性硬化的精准与个体化治疗
- Author:
Jinzhou FENG
1
;
Xinyue QIN
Author Information
1. 重庆医科大学附属第一医院神经内科，重庆 400016
- Keywords:
Multiple sclerosis;
Disease modified therapeutic;
Remission;
Personalized treatment
- From:
Chinese Journal of Neurology
2023;56(7):721-728
- CountryChina
- Language:Chinese
-
Abstract:
Disease-modifying therapy (DMT), the dominating treatment for the remission stage of multiple sclerosis (MS), has reshaped the treatment situation of MS in China due to the increasing number of DMT drugs introduced since 2018. However, the current treatment status is still not satisfied because of the long-time lack of DMT drugs in the past and the latest advances in the diagnosis and treatment of MS. The treatment strategies and goals of MS advanced continuously attributed to the more clarified pathophysiology, more optional DMT drugs and more surveillance methods in disease progression and therapeutic efficacy combined with MRI and biomarkers,etc. Personalized treatment and follow-up protocol established on evidence based prognostication, drug and patient-related factors, probably will be one of the most optimal treatment algorithm in the future. Here is a comprehensive review on how to perform this personalized treatment based on national conditions.
